Pharmaceutical combinations of an angiotensin receptor antagonist and an NEP inhibitor

Details for Australian Patent Application No. 2006311481 (hide)

Owner Novartis AG

Inventors Godtfredsen, Sven Erik; Blacklock, Thomas J.; Sutton, Paul Allen; Prashad, Mahavir; Liu, Yugang; Girgis, Michael J.; Feng, Lili; Hu, Bin; Karpinski, Piotr

Agent Davies Collison Cave

Pub. Number AU-B-2006311481

PCT Pub. Number WO2007/056546

Priority 60/822,086 11.08.06 US; 60/789,332 04.04.06 US; 60/735,093 09.11.05 US; 60/735,541 10.11.05 US

Filing date 8 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 25 February 2010

International Classifications

A61K 31/216 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2007/056546 Priority application(s): WO2007/056546

1 May 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Godtfredsen, Sven Erik; Blacklock, Thomas J.; Sutton, Paul Allen; Prashad, Mahavir; Liu, Yugang; Girgis, Michael J.; Feng, Lili; Hu, Bin and Karpinski, Piotr

25 February 2010 Application Accepted

  Published as AU-B-2006311481

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311482-Acellularized biomaterial from embryonic stem cells

2006311475-TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy